ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyrimidines ∟ Pyrimidinones ∟ Barbiturates ∟ Amobarbital 9 coordinate concepts ∟ Barbital \| ∟ Hexobarbital \| ∟ Mephobarbital \| ∟ Methohexital \| ∟ Murexide \| ∟ Pentobarbital \| ∟ Phenobarbital \| ∟ Secobarbital \| ∟ Thiobarbiturates X
Broader terms:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyrimidines ∟ Pyrimidinones ∟ Barbiturates ∟ Amobarbital Barbiturates > Pyrimidinones > Pyrimidines > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) X
Scope note:	A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565) X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1999-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	lkwX
recordOriginator*:	NLMX
Type:	Concept X
Coordinate terms:	Barbital \| Hexobarbital \| Mephobarbital \| Methohexital \| Murexide \| Pentobarbital \| Phenobarbital \| Secobarbital \| Thiobarbiturates X
URI:	X
Labels and equivalent concepts:	Amobarbitaali (fi) Novopharm Brand of Amobarbital Sodium (en, replaced) Miquel Brand of Amorbarbital (en, replaced) Lilly Brand of Amobarbital Sodium (en, replaced) Pentymal (en, replaced) Protea Brand of Amobarbital Sodium (en, replaced) Transital (en, replaced) Sodium Amytal (en, replaced) Sodium Amobarbital (en, replaced) Lilly Brand of Amobarbital (en, replaced) ICN Brand of Amorbarbital (en, replaced) Bramble Brand of Amobarbital Sodium (en, replaced) Amylobarbitone (en, replaced) Adams Brand of Amorbarbital (en, replaced) Fawns & McAllan Brand of Amorbarbital (en, replaced) Flynn Brand of Amobarbital (en, replaced) Houdé Brand of Amobarbital Sodium (en, replaced) Hosbon Brand of Amorbarbital (en, replaced) Flynn Brand of Amobarbital Sodium (en, replaced) Adams Brand of Amobarbital Sodium (en, replaced) X
Share:	X